ArticleMedicine2026
Demographic time bomb in COPD (1990-2050): A joinpoint-APC-BAPC modeling study on diverging risk factor attributions across age and SDI spectrums.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Funding
Abstract
Chronic obstructive pulmonary disease (COPD) is a leading global cause of morbidity and mortality, characterized by irreversible airflow limitation and progressive symptoms. Despite declining age-standardized rates (ASRs), absolute burdens are rising due to population aging and growth, particularly in low- and middle-Sociodemographic Index (SDI) regions. This study provides the first comprehensive analysis of COPD epidemiology from 1990 to 2021 using Global Burden of Disease 2021 data, integrating multimodel projections to 2050 and risk factor attribution across SDI quintiles. The study extracted COPD incidence, prevalence, mortality, and disability-adjusted life years (DALYs) from the Global Burden of Disease 2021 study (204 countries, 1990-2021). Trends were analyzed via Joinpoint regression, average annual percentage change, age-period-cohort models, and decomposition analysis (population growth/aging/epidemiological shifts). Risk factor burdens (smoking, ambient PM2.5, and household air pollution) were quantified using population attributable fractions. Bayesian age-period-cohort models projected the age-standardized incidence rate, age-standardized mortality rate, and age-standardized DALY rate to 2050. Globally, the age-standardized incidence rate, age-standardized mortality rate, and DALY rate declined (average annual percentage change: -0.05%, -1.49%, and -1.48%, respectively), while absolute cases, deaths, and DALYs increased (213.4 million cases and 1.69 million deaths in 2021). Low-/middle-SDI regions exhibited 2- to 3-fold higher ASRs than high-SDI areas. An inverted V-shaped relationship emerged between SDI and COPD burden, peaking at an SDI of 0.4 to 0.6. Smoking (38%-55% of DALYs), ambient PM2.5 (15%-25%), and household air pollution (0%-55%) dominated risk factors, with marked SDI-based heterogeneity. Projections indicate stable/declining ASRs globally to 2050, but rising absolute burdens in low-SDI nations. COPD remains a critical public health challenge, with shifting burdens from mortality to high prevalence. Targeted interventions in low-SDI regions - clean energy adoption, community spirometry screening, and culturally tailored tobacco control - are imperative to meet the United Nations 2030 noncommunicable disease mortality targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.